Leafy Tunnel
Venture capitalLondon · Seed–Series A · 2 people tracked
Investment thesis
Leafy Tunnel invests directly in companies advancing alternative medicine, specifically medicinal cannabis and psychedelic therapies. The firm backs pioneers working on research, development, and commercialisation of these treatments, which it views as transformative modalities for mental and emotional healing when applied in controlled, therapeutic settings. It seeks entrepreneurs and startups aligned with its vision for the future of alternative medicine and its potential to reshape healthcare. Its investment approach emphasises rigorous analysis, honest feedback, and a commitment to ethical and sustainable practices, while leveraging its network, expertise, and resources to support portfolio companies.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's website
Co-founder of Leafy Tunnel. In 2013 he founded Blue Wire Capital, a multi-strategy firm investing in European venture funds, technology, and life science companies. Holds BA and MBA degrees.
Principal at Leafy Tunnel who started his career at EY in Washington DC before working in corporate finance at US cannabis company Holistic Industries. He holds Finance and Accounting degrees from the University of Maryland, an MBA from London Business School, and a CPA license.
What they invest in
from 3 of 9 portfolio companiesBiotech ×3Mental Health ×3Deep Tech ×2Medical Devices ×2Digital Health ×1
Investments · 9 tracked
founders shown can be your intro pathAtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.
BiotechDeep TechDigital HealthMedical DevicesMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)Christian Angermayer(Founder and Chairman of the Board)
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerSrinivas Rao
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.
BiotechDeep TechMental Health
Principals & officers · per Companies House
what is this? ⓘNikolay Tretiyakov — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors
Frequently asked questions
- What stage does Leafy Tunnel invest at?
- Leafy Tunnel invests at the Seed, Series A stages.
- What sectors does Leafy Tunnel focus on?
- Leafy Tunnel focuses on Biotech, Healthtech, Medical Devices, Mental Health, Wellness & Fitness.
- Where is Leafy Tunnel located?
- Leafy Tunnel is headquartered in London, GB.
Media · Podcasts & interviews
featuring the teamProfessionally Cannabis | Bek Muslimov & Nikolay Tretiyakov, Co-Founders of Leafy Tunnel | EP62 - YouTube
Global Cannabis Intelligence · Nikolay Tretiyakov
Similar investors
JAZZ Venture Partners is a venture capital firm investing in early and growth stage companies at the convergence of technology, science, and humanity, across enterprise, wellness, healthcare, and consumer markets.
Foreground Capital is a venture capital firm investing in early-stage women's health startups, addressing conditions that affect women directly, differently, and disproportionately across biopharma, devices, diagnostics, digital health, tech-enabled services, and consumer health.
PsyMed Ventures is an early-stage venture firm investing in neuroscience and frontier technologies aimed at improving brain and mental health.
Noetic is a venture firm backing early-stage technologies aimed at improving mental health and overall wellbeing.
Bonaventure Equity (BVE) is an early-stage venture capital firm founded and run by entrepreneurs that invests in science-driven healthcare startups, with a focus on cannabinoid and psychedelic medicine.